Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Steven J. Bark

Steven J. Bark

University of Houston, USA

Title: A Mass Spectrometry Perspective on Dormancy and Antibiotic Tolerance in Bacteria

Biography

Biography: Steven J. Bark

Abstract

Dormancy is a protective state where diverse bacteria including M. tuberculosis, S. aureus, T. pallidum (syphilis), and B. burgdorferi (Lyme Disease) curtail metabolic activity to survive severe external stresses including antibiotics. Dormancy appears to consist of a continuum of interrelated states including viable but nonculturable (VBNC) and persistence states implicated in antibiotic tolerance, reemergence from latent infections, and even quorum sensing and biofilm formation. To eliminate dormancy as a mechanism for antibiotic tolerance, we must bridge a critical gap in current knowledge; our limited understanding of the protein mechanisms regulating persistence and VBNC dormancy states. To elucidate some of these mechanisms, we have queried the VBNC state of Micrococcus luteus NCTC 2665 (MI-2665) by quantitative proteomics combining gel electrophoresis, HPLC and tandem mass spectrometry. MI-2665 is well suited for these studies being a non-pathogenic actinobacterium containing a small 2.5 Mb, high GC-content genome and exhibiting a well-defined VBNC state induced by nutrient deprivation. The MI-2665 VBNC state demonstrated a loss of protein diversity accompanied by upregulation of 18 proteins that are conserved across Actinobacteria, of which 14 have not been previously identified. In this talk, I will discuss these proteins and their implication of an anaplerotic strategy in VBNC transition exploiting the glyoxylate shunt, redox and amino acid metabolism, and ribosomal regulation. These results indicate a VBNC protein-level signature and suggest the viability of MI-2665 as model for dissecting the protein mechanisms underlying this stress response. I will also discuss the broader implications of our results for understanding protein regulation of dormancy and for therapeutic targeting of dormant bacterial infections.